CNBC’s Jim Cramer delivers his daily Mad Dash.

Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...

In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...

Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced it will host a live webcast ...

Morgan Stanley said the recent weakness in U.S. semiconductor stocks is a sign that the market gains are broadening, with ...

The artificial intelligence buildout has run headlong into a physical bottleneck: electricity. Data centers are demanding ...

AVE has made a breakthrough with a phase III insomnia trial for its soft gel cannabidiol to manage sleeplessness. ... Read ...

The FDA is fast-tracking Regeneron's planned drug facility in Saratoga County through a new federal pilot program. The ...

As Greater Boston’s biotech industry sheds jobs, three unlikely regions are showing promise as up-and-coming hubs.

Morgan Stanley says U.S. equity-market leadership is beginning to expand beyond the semiconductor and AI infrastructure stocks that have driven much of the market’s recent performance. The firm ...

A Congressional investigation is looking into whether drug trials in China that involved U.S. companies possibly took place ...

Met a bulin, a Texas-based biotechnology company led by Hua Tu, PhD, is working to develop an ultra-stable insulin formulation that remains viable even at high temperatures. “Insulin instability has ...